Takeda Targets Dr. Reddy's Over Generic Dexilant
Takeda Pharmaceutical Co. Ltd. launched a patent infringement suit Friday in New York over Dr. Reddy's Laboratories Ltd.'s efforts to manufacture a generic version of acid reflux treatment Dexilant....To view the full article, register now.
Already a subscriber? Click here to view full article